ForeseeHome AMD Monitoring Program Information for Physicians

It is widely accepted that the earlier you treat neovascular age-related macular degeneration, the better the patient’s final visual outcome will likely be. Early treatment requires early detection. True early detection, before a patient experiences visual symptoms, requires more than just an Amsler grid.

Introducing a major technological advancement for the daily monitoring of age-related macular degeneration: The ForeseeHome AMD Monitor.

The ForeseeHome AMD Monitor is the first FDA cleared system for home based monitoring of patients at risk of vision loss from wet age-related macular degeneration.

The ForeseeHome AMD Monitoring Program links patients and doctors between regular eye exams, providing the advanced frequent monitoring solution needed for true early detection.

Patients use the ForeseeHome AMD Monitor daily from the comfort of their home
Their test results are sent immediately to the Notal Vision Data Monitoring Center
Patient test results are compared to a robust normative database as well as the patient’s own personal threshold
Notal Vision alerts the doctor and patient when statistically significant changes occur so the patient can promptly obtain a comprehensive eye exam
Physicians can view their patient’s data anytime through a secure online connection

The ForeseeHome can detect changes in metamorphopsia, often before the patient notices any visual symptoms, providing important early indications of the possible development of wet AMD. Detection of wet AMD when the patient is asymptomatic, with excellent visual acuity and small lesion size, provides the opportunity for the most effective treatment.

The ForeseeHome AMD Monitoring Program can help you preserve your patients’ vision.